🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

20 recruiting trials

for Moderate to Severe Asthma

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults NCT07301255Phase 220 sites📍 Birmingham📍 Los Angeles📍 San Jose Enveda Therapeutics · Tests: ENV-294, Placebo Study of CM512 Injection in Subjects With Moderate-to-severe Asthma NCT07011524Phase 21 site📍 Guangzhou Keymed Biosciences Co.Ltd · Tests: CM512 injection, Placebo CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma NCT07241117Phase 47 sites📍 St Louis📍 St Louis📍 St Louis Washington University School of Medicine · Tests: Implementation bundle A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma NCT07372287Phase 31 site📍 Shanghai CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · Tests: CM326, Placebo PULmonary Stimulation for Asthma Relief NCT07709754NA3 sites📍 Denver📍 Gainesville📍 Orlando Spiro Medical, Inc. · Tests: Spinal Cord Stimulation A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma NCT06977581Phase 2137 sites📍 Mobile📍 Chandler📍 Lancaster Pfizer · Tests: PF-07275315, Placebo Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma NCT07120503Phase 273 sites📍 Los Angeles📍 San Jose📍 Melbourne Windward Bio · Tests: WIN378, Placebo Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department NCT05691218NA1 site📍 Poitiers Poitiers University Hospital · Tests: Standard Nebulization, A - Vibrating mesh nebulization, B - Vibrating mesh nebulisation and high-flow nasal cannula hea… A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma NCT07219173Phase 2119 sites📍 Tempe📍 Newport Beach📍 Northridge Eli Lilly and Company · Tests: Brenipatide, Brenipatide, Placebo VENTURI (VENTilation Using Respiratory Imaging) NCT07282886Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate pMDI, Fluticasone Furoate/Umeclidinium/Vilanterol 100 MC… Evaluation of Safety, Side Effects, and How the Drug, Inhaled CHF10136, Is Absorbed, Modified and Removed From the Body in Healthy Adults and Adults With Asthma NCT07851623Phase 13 sites📍 Leeds📍 London📍 Manchester Chiesi Farmaceutici S.p.A. · Tests: CHF10136, CHF10136 matched placebo Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations NCT07112456Phase 21 site📍 Muscat Oman Medical Speciality Board · Tests: Nebulized ketamine (0.5 mg/kg in normal saline to a total volume of 5ml) plus standard asthma excaerbationcare, Placebo… A Study of CM310 in Subjects With Moderate to Severe Asthma NCT05761028Phase 2, Phase 31 site📍 Beijing CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Tests: CM310, Placebo A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma NCT07323654Phase 281 sites📍 Lancaster📍 Long Beach📍 Northridge Kymera Therapeutics, Inc. · Tests: KT-621, Placebo Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma NCT05008965Phase 213 sites📍 Kaohsiung City📍 Kaohsiung City📍 New Taipei City Oneness Biotech Co., Ltd. · Tests: FB825, Placebo Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping NCT06385236Phase 43 sites📍 Scottsdale📍 La Jolla📍 New Haven University of California, San Diego · Tests: Dupilumab, Benralizumab Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients NCT07342803Phase 21 site📍 Shanghai Longbio Pharma · Tests: LP-003 Injection, Omalizumab, Placebo Phase II Trial of RC1416 Injection in Asthma NCT07403487Phase 244 sites📍 Anqing📍 Suzhou📍 Beijing Nanjing RegeneCore Biotech Co., Ltd. · Tests: RC1416, RC1416 Placebo Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma NCT04743791Phase 41 site📍 Pittsburgh Sally E. Wenzel MD · Tests: Dupilumab, Placebo Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma NCT06837922Phase 31 site📍 Guangzhou Shanghai Mabgeek Biotech.Co.Ltd · Tests: MG-K10/Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy